{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06336356",
            "orgStudyIdInfo": {
                "id": "D6970C00011"
            },
            "organization": {
                "fullName": "AstraZeneca",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension",
            "officialTitle": "A Randomised, Double-blind, Placebo-controlled Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone Stimulation Test Following Treatment With Baxdrostat for 8 Weeks in Participants With Uncontrolled Hypertension",
            "therapeuticArea": [
                "Cardiovascular"
            ],
            "study": "a-study-to-evaluate-cortisol-reserve-in-response-to-adrenocorticotropic-hormone-acth-stimulation-test-following-baxdrostat-treatment-compared-to-placebo-in-participants-with-uncontrolled-hypertension"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-22",
            "studyFirstSubmitQcDate": "2024-03-22",
            "studyFirstPostDateStruct": {
                "date": "2024-03-28",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-11",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "AstraZeneca",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main purpose of this study is to assess the serum free cortisol response after ACTH stimulation test at baseline and at Week 8 in participants with uncontrolled hypertension.",
            "detailedDescription": "This is a placebo-controlled study to evaluate cortisol reserve after ACTH stimulation test following treatment with 2 milligrams (mg) baxdrostat versus placebo.\n\nThe study consists of 3 period:\n\n* 4-week screening period.\n* An 8-week double-blind treatment period.\n* A safety follow-up 2 weeks after last dose.\n\nParticipants will be randomized in a 2:1 ratio to one of 2 treatment arms:\n\n1. Baxdrostat\n2. Placebo\n\nParticipants will receive either baxdrostat or placebo.\n\nThe overall study duration will be up to 16 weeks."
        },
        "conditionsModule": {
            "conditions": [
                "Uncontrolled Hypertension"
            ],
            "keywords": [
                "Adrenocorticotropic hormone stimulation"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 45,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm 1: Baxdrostat 2 mg",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive baxdrostat 2 mg tablet orally once daily.",
                    "interventionNames": [
                        "Drug: Baxdrostat"
                    ]
                },
                {
                    "label": "Arm 2: Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will receive placebo tablet orally once daily.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Baxdrostat",
                    "description": "Baxdrostat will be administered orally once daily.",
                    "armGroupLabels": [
                        "Arm 1: Baxdrostat 2 mg"
                    ],
                    "otherNames": [
                        "RO6836191,",
                        "CIN-107"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo will be administered orally once daily.",
                    "armGroupLabels": [
                        "Arm 2: Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Individual Cortisol Level",
                    "description": "The serum free cortisol response before and after ACTH stimulation test will be evaluated.",
                    "timeFrame": "At baseline and Week 8"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of Participants with Abnormal Stimulated Cortisol",
                    "description": "Total abnormal serum cortisol response after ACTH stimulation test at Week 8 will be evaluated.",
                    "timeFrame": "At Week 8"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participants with mean seated systolic blood pressure (SBP) on automated office blood pressure measurement (AOBPM) greater than equal to (\\>=) 130 millimeter of mercury (mmHg) and less than (\\<) 170 mmHg at screening.\n* Participants with mean seated SBP on AOBPM of \\>=130 mmHg and \\< 170 mmHg at randomization.\n* Participants must have a stable regimen of \\>=1 antihypertensive medication (at least one should be a diuretic), for at least 4 weeks prior to screening.\n* Participants must have an estimated glomerular filtration rate (eGFR) \\>=45 milliliter per minute (mL/min)/1.73-meter square (m\\^\u00b2) at screening.\n* Participants must have a serum potassium+ (K+) level \\>=3.5 and \\< 5.0 millimole per liter (mmol/L) at screening.\n\nExclusion Criteria:\n\n* Mean seated diastolic blood pressure (DBP) on AOBPM \\>=110 mmHg at randomization.\n* Prior treatment (within the 4 weeks before screening) with angiotensin receptor Blocker (ARBs) and angiotensin converting enzyme inhibitor (ACEIs) (both taken simultaneously).\n* Serum sodium (Na+) level \\< 135 millimole per liter (mmol/L) at screening, determined as per central laboratory.\n* New York heart association functional heart failure (HF) Class IV at screening.\n* Planned percutaneous coronary intervention/coronary artery bypass grafting or percutaneous coronary intervention/coronary artery bypass grafting done within 6 months prior to screening.\n* Uncontrolled diabetes with glycated haemoglobin (HbA1c) \\> 10.0% (86 mmol/mol) at screening.\n* Fridericia's corrected QT (QTcF) value \\> 470 milliseconds (ms) at screening, unless having a pacemaker.\n* Heart rate \\< 45 or \\> 110 beats/min in a resting position, as per vital signs assessment.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "130 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "AstraZeneca Clinical Study Information Center",
                    "role": "CONTACT",
                    "phone": "1-877-240-9479",
                    "email": "information.center@astrazeneca.com"
                }
            ],
            "locations": [
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85018",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Tempe",
                    "state": "Arizona",
                    "zip": "85281",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.41477,
                        "lon": -111.90931
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Chula Vista",
                    "state": "California",
                    "zip": "91910",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.64005,
                        "lon": -117.0842
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Montclair",
                    "state": "California",
                    "zip": "91763",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.07751,
                        "lon": -117.68978
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Tarzana",
                    "state": "California",
                    "zip": "91356",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.17334,
                        "lon": -118.55397
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60643",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Metairie",
                    "state": "Louisiana",
                    "zip": "70006",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.98409,
                        "lon": -90.15285
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Lincoln",
                    "state": "Nebraska",
                    "zip": "68506",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.8,
                        "lon": -96.66696
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77074",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77099",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Research Site",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23502",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via there quest portal Vivli.org. All requests will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.\"Yes\", indicates that AZ are accepting requests for IPD, but this does not mean all requests will be approved.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP"
            ],
            "timeFrame": "AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA/PhRMA Data-Sharing Principles. For details of our timelines, please refer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
            "accessCriteria": "When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org. A Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.",
            "url": "https://vivli.org/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006973",
                    "term": "Hypertension"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "asFound": "Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9912",
                    "name": "Hydrocortisone",
                    "relevance": "LOW"
                },
                {
                    "id": "M155245",
                    "name": "Hydrocortisone 17-butyrate 21-propionate",
                    "relevance": "LOW"
                },
                {
                    "id": "M228609",
                    "name": "Hydrocortisone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M263259",
                    "name": "Hydrocortisone hemisuccinate",
                    "relevance": "LOW"
                },
                {
                    "id": "M3675",
                    "name": "Adrenocorticotropic Hormone",
                    "relevance": "LOW"
                },
                {
                    "id": "M12034",
                    "name": "Melanocyte-Stimulating Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M4901",
                    "name": "beta-Endorphin",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                }
            ]
        }
    },
    "hasResults": false
}